BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lizaola-Mayo BC, Rodriguez EA. Cytomegalovirus infection after liver transplantation. World J Transplant 2020; 10(7): 183-190 [PMID: 32844094 DOI: 10.5500/wjt.v10.i7.183] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Freedman SR, Saunders K, Plazak ME, Ravichandran BR, Saharia KK, Masters BM, Sparkes T. Impact of high MELD scores on CMV viremia following liver transplantation. Transpl Infect Dis 2023;25:e14001. [PMID: 36508446 DOI: 10.1111/tid.14001] [Reference Citation Analysis]
2 Lin SH, Wu KT, Wang CC, Liu TT, Eng HL, Chiu KW. Immunohistochemistry Staining-Proven Cytomegalovirus Colitis in Living Donor Liver Transplantation. Viruses 2022;15. [PMID: 36680155 DOI: 10.3390/v15010115] [Reference Citation Analysis]
3 Naik ND, Elliott J. Mycophenolate Mofetil-Induced Cytomegalovirus Colitis in a Patient With Polymyositis. Cureus 2022. [DOI: 10.7759/cureus.28848] [Reference Citation Analysis]
4 Saner FH, Hoyer DP, Hartmann M, Nowak KM, Bezinover D. The Edge of Unknown: Postoperative Critical Care in Liver Transplantation. JCM 2022;11:4036. [DOI: 10.3390/jcm11144036] [Reference Citation Analysis]
5 Lei H, Tian M, Zhang X, Liu X, Wang B, Wu R, Lv Y. Expansion of Double-Negative T Cells in Patients before Liver Transplantation Correlates with Post-Transplant Infections. J Clin Med 2022;11:3502. [PMID: 35743569 DOI: 10.3390/jcm11123502] [Reference Citation Analysis]
6 Khalil FO, Alsebaey A, Kasemy ZA, Abdelmageed SM, Bedair HM, Abdelsattar S. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert Review of Anti-infective Therapy 2022;20:121-129. [DOI: 10.1080/14787210.2021.1935239] [Reference Citation Analysis]
7 Khalil FO, Alsebaey A, Kasemy ZA, Abdelmageed SM, Bedair HM, Abdelsattar S. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert Review of Anti-infective Therapy 2022;20:121-9. [DOI: 10.1080/14787210.2021.1935239] [Reference Citation Analysis]
8 Lee TY, Choi HJ, Seo CH, Ahn J, Hong TH, You Y. Steroid-Resistant Rejection in Liver Transplant: A Single-Center Study for Risk Factor and Second-Line Treatment. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.10.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Khalil FO, Alsebaey A, Kasemy ZA, Abdelmageed SM, Bedair HM, Abdelsattar S. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert Rev Anti Infect Ther 2021;:1-9. [PMID: 34047252 DOI: 10.1080/14787210.2021.1935239] [Reference Citation Analysis]